Unravelling the utility of modern sulfonylureas from cardiovascular outcome trials and landmark trials: expert opinion from an international panel

Unravelling the utility of modern sulfonylureas from cardiovascular outcome trials and landmark trials: expert opinion from an international panel

Aim: The primary objective of this review is to develop practice-based expert group opinions on the cardiovascular (CV) safety and utility of modern sulfonylureas (SUs) in cardiovascular outcome trials (CVOTs). Background: The United States Food and Drug Administration issued new guidance to the pha...

Full description

Bibliographic Details
Main Authors: S. Kalra, S. Ghosh, A.K. Das, T. Nair, S. Bajaj, G. Priya, R.N. Mehrotra, S. Das, P. Shah, V. Deshmukh, M. Chawla, D. Sanyal, S. Chandrasekaran, D. Khandelwal, A. Joshi, F. Eliana, H. Permana, M.D. Fariduddin, P.K. Shrestha, D. Shrestha, S. Kahandawa, M. Sumanathilaka, A. Shaheed, A.A. Rahim, A. Orabi, A. Al-ani, W. Hussein, D. Kumar, K. Shaikh
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Indian Heart Journal
Subjects:
Cardiosafe
Modern sulfonylureas
Cardiovascular outcome trials
Online Access:http://www.sciencedirect.com/science/article/pii/S0019483220300018

Internet

http://www.sciencedirect.com/science/article/pii/S0019483220300018

Similar Items